Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
The emergence of antibody therapies for Ebola
Andrew Hiatt
, Michael Pauly
, Kevin Whaley
, Xiangguo Qiu
, Gary Kobinger
, Larry Zeitlin
Research output
:
Contribution to journal
›
Review article
›
peer-review
34
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The emergence of antibody therapies for Ebola'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ebola
100%
Antibody Therapy
100%
Monoclonal Antibody
75%
Nonhuman Primate
50%
In Vivo Protection
50%
ZMapp
50%
Rodents
25%
Effector Function
25%
Human Trials
25%
Therapeutic Efficacy
25%
Ebola Virus
25%
West Africa
25%
Exposure Therapy
25%
In Vivo Applications
25%
Comprehensive Testing
25%
Ebola Outbreak
25%
Therapeutic Antibody
25%
In Vitro Neutralization
25%
Antibody Development
25%
Monoclonal Antibody Cocktail
25%
Antibody Efficacy
25%
Plant Use
25%
Glycan Profiling
25%
Production Technology
25%
Plant Production
25%
Immunology and Microbiology
Monoclonal Antibody
100%
ZMapp
50%
Neutralization
25%
Ebola Virus
25%
Glycan
25%
Awareness
25%
Therapeutic Antibodies
25%
In Vitro
25%
Pharmacology, Toxicology and Pharmaceutical Science
Monoclonal Antibody
100%
ZMapp
50%
Clinical Trial
25%
Combination Therapy
25%
Glycan
25%
Ebola Virus
25%